170 related articles for article (PubMed ID: 37737023)
61. Leptomeningeal metastases: a review of evaluation and treatment.
Chamberlain MC
J Neurooncol; 1998 May; 37(3):271-84. PubMed ID: 9524085
[TBL] [Abstract][Full Text] [Related]
62. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
63. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy.
Xu Y; Hu M; Zhang M; Zhong W; Yin X; Sun Y; Chen M; Zhao J; Si X; Wang H; Zhang X; Zhang L; Li J; Guan H; Yang Z; Wang M
Lung Cancer; 2018 Nov; 125():142-149. PubMed ID: 30429013
[TBL] [Abstract][Full Text] [Related]
64. A new approach for leptomeningeal metastases: chemotherapy administered through lumbar intrathecal port.
Comlek S; Saglam S
Arq Neuropsiquiatr; 2021 Sep; 79(9):816-823. PubMed ID: 34669821
[TBL] [Abstract][Full Text] [Related]
65. Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases.
Song Y; Liu P; Huang Y; Guan Y; Han X; Shi Y
Curr Cancer Drug Targets; 2019; 19(8):666-673. PubMed ID: 30332963
[TBL] [Abstract][Full Text] [Related]
66. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
[TBL] [Abstract][Full Text] [Related]
67. Current diagnosis and treatment of leptomeningeal metastasis.
DeAngelis LM
J Neurooncol; 1998; 38(2-3):245-52. PubMed ID: 9696379
[TBL] [Abstract][Full Text] [Related]
68. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
69. New approaches to and current treatment of leptomeningeal metastases.
Chamberlain MC
Curr Opin Neurol; 1994 Dec; 7(6):492-500. PubMed ID: 7532525
[TBL] [Abstract][Full Text] [Related]
70. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment.
Cho KM; Kim YJ; Kim SH; Kim JW; Lee JO; Han JH; Lee KW; Kim JH; Kim CY; Bang SM; Kim IA; Kim JS; Lee JS
Anticancer Res; 2015 Oct; 35(10):5631-8. PubMed ID: 26408736
[TBL] [Abstract][Full Text] [Related]
71. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
72. Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
Zheng MM; Li YS; Jiang BY; Tu HY; Tang WF; Yang JJ; Zhang XC; Ye JY; Yan HH; Su J; Zhou Q; Zhong WZ; Yang XN; Guo WB; Chuai S; Zhang Z; Chen HJ; Wang Z; Liu C; Wu YL
J Thorac Oncol; 2019 May; 14(5):924-932. PubMed ID: 30659989
[TBL] [Abstract][Full Text] [Related]
73. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
[TBL] [Abstract][Full Text] [Related]
74. Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study.
Li H; Zheng S; Lin Y; Yu T; Xie Y; Jiang C; Liu X; Qian X; Yin Z
Clin Lung Cancer; 2023 Mar; 24(2):e94-e104. PubMed ID: 36588048
[TBL] [Abstract][Full Text] [Related]
75. Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.
Phillips PC; Than TT; Cork LC; Hilton J; Carson BS; Colvin OM; Grochow LB
Cancer Res; 1992 Nov; 52(22):6168-74. PubMed ID: 1423260
[TBL] [Abstract][Full Text] [Related]
76. [Clinical trials on intrathecal pemetrexed treated leptomeningeal metastases from solid tumors].
Pan ZY; Song YY; Jiang TC; Yang X; Yang GZ
Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):112-119. PubMed ID: 35073657
[No Abstract] [Full Text] [Related]
77. Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumab.
Dietrich C; Salzmann M; Steinbrecher A; Herbst R; Hassel JC
Immunotherapy; 2021 Sep; 13(13):1079-1083. PubMed ID: 34259028
[TBL] [Abstract][Full Text] [Related]
78. High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature.
Kapke JT; Schneidewend RJ; Jawa ZA; Huang CC; Connelly JM; Chitambar CR
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):189-193. PubMed ID: 31629723
[TBL] [Abstract][Full Text] [Related]
79. Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
Chamberlain M; Soffietti R; Raizer J; Rudà R; Brandsma D; Boogerd W; Taillibert S; Groves MD; Le Rhun E; Junck L; van den Bent M; Wen PY; Jaeckle KA
Neuro Oncol; 2014 Sep; 16(9):1176-85. PubMed ID: 24867803
[TBL] [Abstract][Full Text] [Related]
80. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis.
Nagai A; Terashima M; Harada T; Shimode K; Takeuchi H; Murakawa Y; Nagasaki M; Nakano A; Kobayashi S
Clin Chim Acta; 2003 Mar; 329(1-2):53-60. PubMed ID: 12589965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
